Higher Leverage Against Lung Cancer

The fight against cancer has been progressively forward over the years. The combined efforts of Government, civil society, health advocacy groups have achieved spectacular results. Cancer awareness is increasing, alternative less prone to living cancer born, while medical research and technological progress have enormously leveled fighting against one of the world's leading killer. Classical chemotherapy has been modernized and combined with other treatments such as laser radiation and even organic medicinal products.

Only America, national Institute of health of the US Department of health and social services from its National Cancer Institute Cancer arm reported that the rate of mortality due to cancer is still declining. In its annual report to the nation, the > argued that cancer mortality rates are falling gradually and progress in cancer treatments are constantly rising. In men, 1993-2002 study has registered a decrease of 1.5% of all cases of cancer.Cela death rate is higher compared to the rate of decline of 0.08% of women.

This report has developed the US Department of Health services and a better position to achieve the objectives of health people 2010 campaign.Statistics revealed that lung cancer still routinely leads nation.Bien that a reduction in cancer cases focus on tobacco is reached cancer mortality rates, the challenge of reducing expenses of death is always difficult that it has always been before. With more people smoke cigarettes, lung cancer or bronco remains the leading cause of death by cancer in men and women.

Dubbed as "the most common cancer", lung cancer now is the object of many studies and experiments in many countries with facilities such as the United Kingdom and Australia & advance cancer research programs. A broader knowledge about lung cancer is now available. A classification was established between Small Cell Lung Cancer and non-Small Cell Lung Cancer. Small cell lung cancer is the case where in cancer malignant cells grow in the tissues of the lungs.Three types of small cell Lung Cancer are known: small large Carcinoma, carcinoma and carcinoma small combinée.Fumer second-hand smoking and exposure to asbestos and radon are known causes of small cell Lung Cancer. Current treatments not correctly heal the case of small cell Lung Cancer. However, studies in Germany revealed that surgery (removal of the cancer cells or tumor), post-operative chemotherapy systematic and sustained local treatments (e.g. * radiation therapy *) have a higher probability of polymerization of this type of lung cancer.

Non-Small Cell Lung Cancer, on the other hand, the most common type of cancer of the poumon.Il represents four of every five deaths from lung cancer. There are several known non-petites Lung Cancer types, three major carcinoma Basal Cell Carcinoma, large basal cell carcinoma and adenocarcinoma. Others are pleomorphic, carcinoid tumor and salivary gland carcinoma. As another type of lung cancer, non-Small Cell Lung Cancer is mainly due to smoking (first and second hand), high exposure to air pollution and exposure to chemicals such as asbestos, chromium and arsenic.

In 2005, the New England Journal of Medicine reported a breakthrough in the treatment of non-Small Cell Lung Cancer.He reported that current studies indicate that chemotherapy after non-Small Cell Lung Cancer traditional surgery, treatment can increase patient survival.In a study, an overwhelming 15% increase in survival rates was registered in patients with chemotherapy after surgery.Sixty per cent of those who had post-operative chemotherapy were reported to be still alive five years after surgery with the 54 per cent, which does not.

Furthermore, a study in Switzerland suggested an even greater for treating non-Small Cell Lung Cancer .the breakthrough ' study suggested that, in addition to chemotherapy, a combination of cancer innovative drug Tarceva and Avastin can lead to survival rates more high patient non-Small Cell Lung Cancer.Tarceva is approved in the United States and throughout the Union European for patients with cancer Avastin unsuccessful treatments by chimiothérapie.Aux United States and Europe, is also a popular medicine effective for colorectal cancer, non-small cell lung cancer and cancer of the proposed combination sein.La is meant to serve a struggle stronger against non-Small Cell Lung Cancer, especially for recurring cases.

The US Department of health and social services clearly aims the habit of smoking as the main antagonist in the fight against cancer of the propaganda campaign poumon.Une almost everywhere is to make the American people, if not completely exit, slowing of smoking.

For more information on cancer, cardiovascular health, please visit http://www.healthsnippets.com